A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients

The combination of irinotecan (CPT-11), oxaliplatin (L-OHP), 5-fluorouracil (5-FU) and folinic acid (FA) is one of the possibilities to overcome chemoresistance in advanced colorectal cancer (ACRC) patients. The aim of this study was to determine the tolerability and activity of CPT-11 plus chronomo...

詳細記述

保存先:
書誌詳細
主要な著者: Garufi, C, Bria, E, Vanni, B, Zappalà, A M R, Sperduti, I, Terzoli, E
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2003
主題:
Clinical
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2394458/
https://ncbi.nlm.nih.gov/pubmed/14612895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601382
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料